Automated Time-Resolved Immunofluorometric Assay for Progastrin-Releasing Peptide
Open Access
- 1 May 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 54 (5) , 919-922
Abstract
Background: Small cell lung cancer accounts for approximately 20% of new cases of lung cancer, and advanced disease is prevalent at the time of diagnosis. Neuron-specific enolase (NSE) has been the primary tumor marker in small cell lung cancer but it has relatively low sensitivity in early-stage disease. Progastrin-releasing peptide (proGRP) is a promising alternative or complementary marker for NSE. We have previously described a time-resolved immunofluorometric assay (TR-IFMA) for proGRP that lacked the necessary sensitivity and robustness for use in the routine clinical laboratory. Herein we describe the development of an improved assay using a novel monoclonal antibody pair. Methods: Mice were immunized with different conjugated proGRP peptides, including residues 31–98, 1–98, and preproGRP(-23–125). Pair combinations of the resulting monoclonal antibodies (mAb) were tested. The improved TR-IFMA was compared with the only other available proGRP assay, the proGRP ELISA (IBL). Results: A panel of 12 high-affinity mAbs was produced. The best assay combination was between our original E146 mAb as solid-phase antibody and the new mAb M16 as tracer. The new TR-IFMA had a linear dose-response curve, a wide dynamic range (13–13 500 ng/L), and a limit of detection of 2.8 ng/L. Total CV was <5.6% over the whole measuring range. Bland-Altman difference analysis indicated a significant positive bias between the IFMA and the ELISA. Conclusions: We describe a sensitive and robust mAb-based TR-IFMA for proGRP. The assay is fully automated and displays high quality performance.Keywords
This publication has 14 references indexed in Scilit:
- Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRPTumor Biology, 2007
- Synthesis, Expression and Biological Activity of the Prohormone for Gastrin Releasing Peptide (ProGRP)Endocrinology, 2006
- Use of an In Vivo Biotinylated Single-Chain Antibody as Capture Reagent in an Immunometric Assay to Decrease the Incidence of Interference from Heterophilic AntibodiesClinical Chemistry, 2005
- Characterization of Monoclonal Antibodies Directed against Squamous Cell Carcinoma Antigens: Report of the TD-10 WorkshopTumor Biology, 2004
- Immunometric Assay InterferenceClinical Chemistry, 2002
- A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytesBlood, 2000
- Proteolytic selection for protein folding using filamentous bacteriophagesFolding and Design, 1998
- Pro-gastrin-releasing peptide(31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolaseBritish Journal of Cancer, 1996
- Comparing methods of measurement: why plotting difference against standard method is misleadingThe Lancet, 1995
- [1] Preparation of monoclonal antibodies: Strategies and procedures1981